Israel Englander’s Guardian Pharmacy Services GRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.05M Buy
120,607
+93,413
+344% +$3.62M ﹤0.01% 2995
2026
Q1
$1.02M Sell
27,194
-140,352
-84% -$4.59M ﹤0.01% 4381
2025
Q4
$5.04M Sell
167,546
-174,492
-51% -$4.94M ﹤0.01% 3000
2025
Q3
$8.97M Buy
342,038
+300,587
+725% +$7.16M ﹤0.01% 2498
2025
Q2
$883K Sell
41,451
-19,484
-32% -$440K ﹤0.01% 4501
2025
Q1
$1.3M Buy
+60,935
New +$1.25M ﹤0.01% 4154
2024
Q4
Sell
-176,120
Closed -$2.96M 6568
2024
Q3
$2.96M Buy
+176,120
New +$2.97M ﹤0.01% 3330

Other funds holding GRDN

Israel Englander's GRDN Position: Q2 2026 in Review

Israel Englander increased its Guardian Pharmacy Services (GRDN) stake by 344% in Q2 2026, buying an estimated $3.62M and bringing the position to 120,607 shares worth $5.05M. The position accounts for ﹤0.01% of the portfolio, ranked #2995.

Israel Englander first reported a position in GRDN in Q3 2024 and has held it in 7 quarters since. The position peaked at $8.97M in Q3 2025. 187 funds tracked by Wall St. Rank hold GRDN as of Q2 2026.

  • Israel Englander held 120,607 shares of Guardian Pharmacy Services worth $5.05M as of Q2 2026.
  • Israel Englander bought 93,413 Guardian Pharmacy Services shares in Q2 2026, an estimated $3.62M.
  • Guardian Pharmacy Services made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2995 holding.
  • Israel Englander first reported a position in Guardian Pharmacy Services in Q3 2024 and has held it in 7 quarters since.
  • Israel Englander's Guardian Pharmacy Services position peaked at $8.97M in Q3 2025.
  • 187 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.